Data as of Mar 07
| +0.49 / +0.96%|
The 12 analysts offering 12-month price forecasts for Seattle Genetics Inc have a median target of 47.00, with a high estimate of 60.00 and a low estimate of 24.00. The median estimate represents a -9.23% decrease from the last price of 51.78.
The current consensus among 14 polled investment analysts is to Buy stock in Seattle Genetics Inc. This rating has held steady since February, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.